두개내압 모니터링 시장 보고서 : 제품 종류별, 기술별, 모니터링 종류별, 용도별, 최종사용자별, 지역별(2025-2033년)

The global intracranial pressure monitoring market size reached USD 1.9 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 3.1 Billion by 2033, exhibiting a growth rate (CAGR) of 5.47% during 2025-2033. The increasing incidences of traumatic brain injuries, growing neurological disorders, rising prevalence of strokes, advancements in monitoring technology, growing awareness of early diagnosis, and the need for improved patient outcomes are some of the major factors propelling the market growth.

Intracranial Pressure Monitoring Market Trends:

Increasing Prevalence of Neurological Disorders

The rising incidence of conditions such as traumatic brain injuries, strokes, hydrocephalus, and other neurological disorders necessitates effective monitoring solutions, boosting the demand for ICP monitoring devices. According to The National Institute of Health (NIH), it is estimated that nearly 1.5 to 2 million persons are injured and 1 million succumb to death every year in India. Road traffic injuries are the leading cause (60%) of traumatic brain injuries followed by falls (20%-25%) and violence (10%). Alcohol involvement is known to be present among 15%-20% of traumatic brain injuries at the time of injury. According to the Centers for Disease Control and Prevention (CDC), an estimated 2.5 million people sustain a traumatic brain injury (TBI) each year. Brain injuries are most common in men between the ages of 15 to 24. Children under the age of 5 and older adults over age 75 also have a high incidence of brain injury. This is further projected to increase the intracranial pressure monitoring market revenue during the forecast period.

Significant Advancements in Medical Technology

The rising innovations in monitoring technology, including the development of minimally invasive and non-invasive ICP monitoring techniques, have improved the accuracy, safety, and ease of use of these devices, driving market growth. For instance, in June 2024, as published in a research article in Nature journal, a Chinese research team created a mini-injectable ultrasonic sensor for wireless monitoring of intracranial signals, thereby providing an option that goes beyond the limitations of current clinical instruments. According to the study, the sensors are cubes that are eight cubic millimeters in size, and they are made from biodegradable and stimulus-responsive hydrogels and periodically aligned air columns with a specific acoustic reflection spectrum. Implanted into intracranial space with a puncture needle, the devices can deform in response to physiological environmental changes, resulting in peak frequency shifts of reflected ultrasound waves that can be wirelessly measured by an external ultrasound probe. Such significant advancements are creating a positive intracranial pressure monitoring market outlook across the globe.

Growing Awareness and Early Diagnosis

Increased awareness about the importance of early diagnosis and intervention for brain-related conditions among healthcare providers and patients fuels the demand for ICP monitoring systems. For instance, in March 2024, researchers from King's College London (KCL) developed a deep learning framework for a non-invasive brain-age prediction tool for the early diagnosis of neurological diseases. The study built and made available a set of models for clinical use after training multiple brain models from a variety of magnetic resonance image (MRI) types. Neurological disorders, such as Alzheimer's disease, strokes, multiple sclerosis, and Parkinson's disease, are conditions that affect the brain as well as the nerves found throughout the human body and spinal cord. Advancements like these are pivotal to the early diagnosis of the diseases, which, when coupled with the rising awareness regarding the significance of the early disease diagnosis, are expected to have a positive impact on the intracranial pressure monitoring market forecast.

Intracranial Pressure Monitoring Market Segmentation:

Breakup by Product Type:

• Monitors
• Probes
• Catheters and Kits
• Other Accessories

Monitors accounts for the majority of the market share

The demand for monitors in the market is driven by the increasing prevalence of traumatic brain injuries, strokes, and neurological disorders, necessitating accurate and continuous monitoring. Advancements in medical technology, including non-invasive and minimally invasive monitors, enhance patient safety and comfort, boosting their adoption. The growing awareness about early diagnosis and intervention for brain-related conditions, coupled with improved healthcare infrastructure and increased healthcare spending, particularly in developed regions, further propels the intracranial pressure monitoring demand.

Breakup by Technology:

• Invasive
  • External Ventricular Drainage (EVD)
  • Microtransducer ICP Monitoring
• Non-invasive
  • Transcranial Doppler Ultrasonography
  • Tympanic Membrane Displacement
  • Optic Nerve Sheath Diameter
  • MRI/CT
  • Others

Invasive holds the largest share of the industry

The demand for invasive technology in the market is driven by its high accuracy and reliability in critical care settings. Pioneering the many intracranial pressure monitoring market recent developments, invasive technology is essential for managing severe traumatic brain injuries, hydrocephalus, and other neurological conditions requiring precise pressure measurements. Additionally, advancements in invasive monitoring devices have enhanced safety and ease of use, further boosting their adoption. The ability to provide continuous, real-time data critical for timely clinical interventions also drives the demand for invasive ICP monitoring technologies, thereby creating a positive market outlook across the globe.

Breakup by Monitoring Type:

• Intraventricular
• Intraparenchymal
• Epidural
• Others

Intraventricular represents the leading market segment

The demand for intraventricular monitoring in the market is driven by its superior accuracy and ability to both monitor and drain cerebrospinal fluid (CSF), making it crucial for managing severe traumatic brain injuries and hydrocephalus. This method provides continuous, real-time pressure data and therapeutic intervention capabilities, essential for critical care. Additionally, the increasing prevalence of neurological disorders and the need for precise intracranial pressure management in intensive care units further boost the demand for intraventricular monitoring.

Breakup by Application:

• Traumatic Brain Injury
• Intracerebral Hemorrhage
• Meningitis
• Others

Traumatic Brain Injury exhibits a clear dominance in the market

The demand for intracranial pressure (ICP) monitoring in traumatic brain injury (TBI) is driven by the need for precise, real-time pressure data to prevent secondary brain damage. Early and accurate ICP monitoring is crucial for guiding treatment decisions, reducing mortality rates, and improving patient outcomes. The high prevalence of TBIs, particularly from accidents and sports injuries, coupled with advancements in monitoring technology and increased awareness among healthcare providers, are further propelling the demand for ICP monitoring in this application.

Breakup by End-User:

• Hospitals
• Home Care
• Trauma Centers
• Others

Hospitals dominates the market

The demand for intracranial pressure (ICP) monitoring in hospitals is driven by the high incidence of traumatic brain injuries, strokes, and neurological disorders requiring critical care. Hospitals are equipped with advanced medical infrastructure and specialized staff capable of utilizing ICP monitoring technologies effectively. The emphasis on early diagnosis and intervention, coupled with the need for continuous, accurate monitoring in intensive care units, further boosts demand. Additionally, hospitals' ability to integrate the latest advancements in ICP monitoring ensures better patient outcomes and drives the intracranial pressure monitoring market growth.

Breakup by Region:

• North America
  • United States
  • Canada
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa

North America leads the market, accounting for the largest intracranial pressure monitoring market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for intracranial pressure monitoring.

In North America, the intracranial pressure monitoring market is driven by the high prevalence of traumatic brain injuries and neurological disorders, advanced healthcare infrastructure, and significant healthcare expenditure. According to a study by the University of Pennsylvania, each year, an estimated 2 million Americans suffer some form of traumatic brain injury. Brain injury is suffered by someone in America, usually a young person, every 15 seconds. Each year, approximately 100,000 people die from TBI and 500,000 more are permanently disabled. 80,000 people experience the onset of long-term disability following a severe brain injury annually. Approximately 5.3 million Americans, more than 2% of the US population - are living with a disability that results from TBI. The cost of treating, rehabilitating, and caring for the victims of traumatic brain injury costs the U.S. approximately $30 billion each year. The region's strong adoption of innovative medical technologies and increased awareness of early diagnosis and intervention for brain-related conditions further boost demand. Additionally, the presence of leading medical device manufacturers and ongoing research and development activities contribute to the market's growth in North America.

Competitive Landscape:

• The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the intracranial pressure monitoring industry include DePuy Synthes (Johnson & Johnson), HeadSense Medical Ltd., Integra Lifesciences Corporation, LINET Ltd., Medtronic plc, Natus Medical Incorporated, Raumedic AG (Rehau), Sophysa, and Spiegelberg Gmbh (SHS).

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

• The intracranial pressure monitoring market features key players such as Integra LifeSciences, Medtronic, and Natus Medical. These intracranial pressure monitoring companies dominate the market with advanced product offerings and extensive distribution networks. Emerging players focus on innovative, non-invasive technologies to gain a competitive edge. Strategic collaborations, mergers, and acquisitions are common as companies aim to expand their market presence. Continuous research and development (R&D) efforts are driving advancements, ensuring intense competition and rapid technological evolution within the market. For instance, in October 2023, Larimar Therapeutics announced that the FDA has cleared a 4-week, placebo-controlled exploration trial assessing its investigational Friedrich ataxia (FA) agent CTI-1601 in doses of 50 mg after the company released positive phase 2 data earlier this year. The company's open-label extension (OLE), which will assess 25 mg of CTI-1601 daily, was also cleared for initiation by the FDA.

Key Questions Answered in This Report

• 1.What was the size of the global intracranial pressure monitoring market in 2024?
• 2.What is the expected growth rate of the global intracranial pressure monitoring market during 2025-2033?
• 3.What are the key factors driving the global intracranial pressure monitoring market?
• 4.What has been the impact of COVID-19 on the global intracranial pressure monitoring market?
• 5.What is the breakup of the global intracranial pressure monitoring market based on the product type?
• 6.What is the breakup of the global intracranial pressure monitoring market based on the technology?
• 7.What is the breakup of the global intracranial pressure monitoring market based on monitoring type?
• 8.What is the breakup of the global intracranial pressure monitoring market based on the application?
• 9.What is the breakup of the global intracranial pressure monitoring market based on the end-user?
• 10.What are the key regions in the global intracranial pressure monitoring market?
• 11.Who are the key players/companies in the global intracranial pressure monitoring market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Intracranial Pressure Monitoring Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Product Type

• 6.1 Monitors
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Probes
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 Catheters and Kits
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast
• 6.4 Other Accessories
  • 6.4.1 Market Trends
  • 6.4.2 Market Forecast

7 Market Breakup by Technology

• 7.1 Invasive
  • 7.1.1 Market Trends
  • 7.1.2 Major Types
    • 7.1.2.1 External Ventricular Drainage (EVD)
    • 7.1.2.2 Microtransducer ICP Monitoring
  • 7.1.3 Market Forecast
• 7.2 Non-invasive
  • 7.2.1 Market Trends
  • 7.2.2 Major Types
    • 7.2.2.1 Transcranial Doppler Ultrasonography
    • 7.2.2.2 Tympanic Membrane Displacement
    • 7.2.2.3 Optic Nerve Sheath Diameter
    • 7.2.2.4 MRI/CT
    • 7.2.2.5 Others
  • 7.2.3 Market Forecast

8 Market Breakup by Monitoring Type

• 8.1 Intraventricular
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Intraparenchymal
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Epidural
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast
• 8.4 Others
  • 8.4.1 Market Trends
  • 8.4.2 Market Forecast

9 Market Breakup by Application

• 9.1 Traumatic Brain Injury
  • 9.1.1 Market Trends
  • 9.1.2 Market Forecast
• 9.2 Intracerebral Hemorrhage
  • 9.2.1 Market Trends
  • 9.2.2 Market Forecast
• 9.3 Meningitis
  • 9.3.1 Market Trends
  • 9.3.2 Market Forecast
• 9.4 Others
  • 9.4.1 Market Trends
  • 9.4.2 Market Forecast

10 Market Breakup by End-User

• 10.1 Hospitals
  • 10.1.1 Market Trends
  • 10.1.2 Market Forecast
• 10.2 Home Care
  • 10.2.1 Market Trends
  • 10.2.2 Market Forecast
• 10.3 Trauma Centers
  • 10.3.1 Market Trends
  • 10.3.2 Market Forecast
• 10.4 Others
  • 10.4.1 Market Trends
  • 10.4.2 Market Forecast

11 Market Breakup by Region

• 11.1 North America
  • 11.1.1 United States
    • 11.1.1.1 Market Trends
    • 11.1.1.2 Market Forecast
  • 11.1.2 Canada
    • 11.1.2.1 Market Trends
    • 11.1.2.2 Market Forecast
• 11.2 Asia Pacific
  • 11.2.1 China
    • 11.2.1.1 Market Trends
    • 11.2.1.2 Market Forecast
  • 11.2.2 Japan
    • 11.2.2.1 Market Trends
    • 11.2.2.2 Market Forecast
  • 11.2.3 India
    • 11.2.3.1 Market Trends
    • 11.2.3.2 Market Forecast
  • 11.2.4 South Korea
    • 11.2.4.1 Market Trends
    • 11.2.4.2 Market Forecast
  • 11.2.5 Australia
    • 11.2.5.1 Market Trends
    • 11.2.5.2 Market Forecast
  • 11.2.6 Indonesia
    • 11.2.6.1 Market Trends
    • 11.2.6.2 Market Forecast
  • 11.2.7 Others
    • 11.2.7.1 Market Trends
    • 11.2.7.2 Market Forecast
• 11.3 Europe
  • 11.3.1 Germany
    • 11.3.1.1 Market Trends
    • 11.3.1.2 Market Forecast
  • 11.3.2 France
    • 11.3.2.1 Market Trends
    • 11.3.2.2 Market Forecast
  • 11.3.3 United Kingdom
    • 11.3.3.1 Market Trends
    • 11.3.3.2 Market Forecast
  • 11.3.4 Italy
    • 11.3.4.1 Market Trends
    • 11.3.4.2 Market Forecast
  • 11.3.5 Spain
    • 11.3.5.1 Market Trends
    • 11.3.5.2 Market Forecast
  • 11.3.6 Russia
    • 11.3.6.1 Market Trends
    • 11.3.6.2 Market Forecast
  • 11.3.7 Others
    • 11.3.7.1 Market Trends
    • 11.3.7.2 Market Forecast
• 11.4 Latin America
  • 11.4.1 Brazil
    • 11.4.1.1 Market Trends
    • 11.4.1.2 Market Forecast
  • 11.4.2 Mexico
    • 11.4.2.1 Market Trends
    • 11.4.2.2 Market Forecast
  • 11.4.3 Others
    • 11.4.3.1 Market Trends
    • 11.4.3.2 Market Forecast
• 11.5 Middle East and Africa
  • 11.5.1 Market Trends
  • 11.5.2 Market Breakup by Country
  • 11.5.3 Market Forecast

12 SWOT Analysis

• 12.1 Overview
• 12.2 Strengths
• 12.3 Weaknesses
• 12.4 Opportunities
• 12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

• 14.1 Overview
• 14.2 Bargaining Power of Buyers
• 14.3 Bargaining Power of Suppliers
• 14.4 Degree of Competition
• 14.5 Threat of New Entrants
• 14.6 Threat of Substitutes

15 Price Analysis

16 Competitive Landscape

• 16.1 Market Structure
• 16.2 Key Players
• 16.3 Profiles of Key Players
  • 16.3.1 DePuy Synthes (Johnson & Johnson)
    • 16.3.1.1 Company Overview
    • 16.3.1.2 Product Portfolio
  • 16.3.2 HeadSense Medical Ltd.
    • 16.3.2.1 Company Overview
    • 16.3.2.2 Product Portfolio
  • 16.3.3 Integra Lifesciences Corporation
    • 16.3.3.1 Company Overview
    • 16.3.3.2 Product Portfolio
    • 16.3.3.3 Financials
    • 16.3.3.4 SWOT Analysis
  • 16.3.4 LINET Ltd.
    • 16.3.4.1 Company Overview
    • 16.3.4.2 Product Portfolio
  • 16.3.5 Medtronic Plc
    • 16.3.5.1 Company Overview
    • 16.3.5.2 Product Portfolio
    • 16.3.5.3 Financials
    • 16.3.5.4 SWOT Analysis
  • 16.3.6 Natus Medical Incorporated
    • 16.3.6.1 Company Overview
    • 16.3.6.2 Product Portfolio
  • 16.3.7 Raumedic AG (Rehau)
    • 16.3.7.1 Company Overview
    • 16.3.7.2 Product Portfolio
  • 16.3.8 Sophysa
    • 16.3.8.1 Company Overview
    • 16.3.8.2 Product Portfolio
  • 16.3.9 Spiegelberg Gmbh (SHS)
    • 16.3.9.1 Company Overview
    • 16.3.9.2 Product Portfolio